ArticleTransplantation and cellular therapy2024

Subsequent Malignancies After CD19-Targeted Chimeric Antigen Receptor T Cells in Patients With Lymphoma.

Rachel Lorenc et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.